Polycystic ovary syndrome: a multifaceted disease from adolescence to adult age.
about
Clinical characteristics in Taiwanese women with polycystic ovary syndromeAndrogen receptor (AR) pathophysiological roles in androgen-related diseases in skin, bone/muscle, metabolic syndrome and neuron/immune systems: lessons learned from mice lacking AR in specific cellsA life course perspective on polycystic ovary syndromeEffects of di(2-ethylhexyl) phthalate (DEHP) on female fertility and adipogenesis in C3H/N mice.Association between follicular fluid leptin and serum insulin levels in nonoverweight women with polycystic ovary syndrome.Interventional studies for polycystic ovarian syndrome in children and adolescents.The impact of female obesity on the outcome of fertility treatmentAn interesting cause of hyperandrogenemic hirsutismMetformin and polycystic ovary syndrome.Gene expression profiling in the aging ovary.Clinically relevant known and candidate genes for obesity and their overlap with human infertility and reproduction.Effects of Probiotic Supplementation on Pancreatic β-cell Function and C-reactive Protein in Women with Polycystic Ovary Syndrome: A Randomized Double-blind Placebo-controlled Clinical Trial.Effect of Treatment with Metformin on Omentin-1, Ghrelin and other Biochemical, Clinical Features in PCOS Patients.Serum 25-Hydroxyvitamin D Levels, phosphoprotein enriched in diabetes gene product (PED/PEA-15) and leptin-to-adiponectin ratio in women with PCOSPeroxisome proliferator-activated receptor gamma rs1801282 C>G polymorphism is associated with polycystic ovary syndrome susceptibility: a meta-analysis involving 7,069 subjects.Insulin receptor substrate-1 (IRS-1) rs1801278G>A polymorphism is associated with polycystic ovary syndrome susceptibility: a meta-analysisAdrenocortical dysregulation as a major player in insulin resistance and onset of obesity.Polycystic ovary syndrome and female reproduction.A Potential Therapeutic Role of Myoinositol in the Metabolic and Cardiovascular Profile of PCOS Iranian Women Aged between 30 and 40 Years.Targeting insulin sensitivity in the treatment of polycystic ovary syndrome.Hyperandrogenemia influences the prevalence of the metabolic syndrome abnormalities in adolescents with the polycystic ovary syndrome.Impact of obesity on gynecology.Polycystic ovary syndrome: a common but often unrecognized condition.Revisiting hyper- and hypo-androgenism by tandem mass spectrometry.A comprehensive approach in diagnosing the polycystic ovary syndrome.Associations of insulin receptor and insulin receptor substrates genetic polymorphisms with polycystic ovary syndrome: A systematic review and meta-analysis.What does a diagnostic label of 'polycystic ovary syndrome' really mean in adolescence? A review of current practice recommendations.Polycystic ovary syndrome, adipose tissue and metabolic syndrome.Characteristics of different phenotypes of polycystic ovary syndrome in a Bulgarian population.Clinical and biochemical presentation of polycystic ovary syndrome in women between the ages of 20 and 40.Evaluation of vitamin D status and its correlation with oxidative stress markers in women with polycystic ovary syndrome.Anxiety is associated with hormonal and metabolic profile in women with polycystic ovarian syndrome.Impact of elevated thyroid-stimulating hormone levels in polycystic ovary syndrome.Evidence of biochemical hyperandrogenism in women: the limitations of serum testosterone quantitation.
P2860
Q26782559-3BACF6AF-849F-495C-8439-25933FFC1B7CQ27013914-E642CA07-4A4D-49C5-AFBE-C5318FDEA8AFQ27026536-408F2D2D-54A6-4DAF-97C8-2F698CC39FE1Q30318096-DFFA6AFF-5C78-49BD-8903-DD2922AB2906Q33634846-403E9FF4-51D2-44D5-8744-CD56724B1CAFQ33996662-F649B7E6-A03A-4C84-965B-82582C7A47E8Q34157761-E370873B-7D94-48A9-AE3F-EC9B33CB2BA3Q34457689-F65B9E5C-A698-4B9B-ADC4-6ADB3770CE30Q34746925-46C289F6-9289-4020-AE91-7991C8F1CFE9Q35213511-903657D5-1B8A-4694-9759-28C10CBC150DQ35236656-1C23C33D-9441-4DF6-8CC8-62EBEFC31C5EQ35293427-D90AC289-75F3-4630-A668-33E015C3285CQ35323904-2A3845EC-DD24-49D7-AEF8-C2F21F90F0FCQ35802456-C96519FB-87BE-441A-A5A0-C2D67360457DQ36411517-D92DE300-2FAF-43FE-A1FA-5F886B4F729DQ36411527-5CA7D0CC-C620-460F-8BDD-72A4F99381EBQ36958256-92F278A6-9EFF-41CC-9A31-4C98899D61C5Q37029862-0F28DF8A-8639-48AC-AF92-517F50BB2D8AQ37239631-4DE84D18-1A57-4BB8-9183-394D8DA0EE6BQ37570577-4D1B8196-4983-4008-AFAD-76FC1471A6C6Q37630561-2D24F188-E643-4FC6-926E-73C6D3266ACCQ37678420-FDB87B57-0478-483C-B44F-106B21E8E76BQ38010787-0CFBDE8F-C86A-4B5D-86AE-92CB0588563BQ38101855-ED302D92-A41E-4640-81F5-4B586EBBEC4FQ38371865-87836E9C-07DB-473B-9CDE-BE9A1063FBA9Q38381198-5FCDBE8A-9C78-43E5-9177-A792C3A84A18Q38633475-971C9BA3-760B-403D-B95F-10BA44B8FED3Q39393050-01A7AB6E-D023-4DCB-A9A5-58ACA8CA2D58Q43928446-17CFEC77-F188-4BA3-A49C-6761D5183AD9Q44496944-A42A792D-8AB5-4A8B-B464-724382F88CBFQ47137393-46873655-BBC7-4D1C-A3C1-F08AE553CB72Q48865550-8BD311F8-F79E-4002-8A24-3DC8E9A4ABA7Q51299752-F6473EBD-4BA5-488D-8BF1-F601419F92D2Q51345232-484C3C4D-8588-43FF-87F7-55BF1C78C3E0
P2860
Polycystic ovary syndrome: a multifaceted disease from adolescence to adult age.
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
2006年论文
@zh
2006年论文
@zh-cn
name
Polycystic ovary syndrome: a multifaceted disease from adolescence to adult age.
@ast
Polycystic ovary syndrome: a multifaceted disease from adolescence to adult age.
@en
type
label
Polycystic ovary syndrome: a multifaceted disease from adolescence to adult age.
@ast
Polycystic ovary syndrome: a multifaceted disease from adolescence to adult age.
@en
prefLabel
Polycystic ovary syndrome: a multifaceted disease from adolescence to adult age.
@ast
Polycystic ovary syndrome: a multifaceted disease from adolescence to adult age.
@en
P2860
P356
P1476
Polycystic ovary syndrome: a multifaceted disease from adolescence to adult age.
@en
P2093
Alessandra Gambineri
Renato Pasquali
P2860
P304
P356
10.1196/ANNALS.1365.014
P407
P577
2006-12-01T00:00:00Z